Webinar Archives
- Recent
- Maestro
- Life Science
- 20th Schrödinger European User Group Meeting
- What's New
- AI in Life Sciences Series
- Drug Discovery User Group Meeting 2020
- Summer of Science Series
- Chinese Webinar Series 2020
- Multiscale Modeling for Biotherapeutics Symposium
- Biologics
- FEP
- Force Field
- Formulations
- Informatics
- Lead Optimization
- Machine Learning
- MD
- Pharmacophores
- QM
- Target Refinement
- Virtual Screening
- Materials
- 20th Schrödinger European User Group Meeting
- What's New
- Digital Transformation for Chemistry & Materials Innovation
- Summer of Science Series
- Materials Science User Group Meeting 2020
- Chinese Webinar Series 2020
- Multiscale Modeling for Biotherapeutics Symposium
- ALD
- Catalysis and Reactivity
- Formulations
- Informatics
- MD
- Machine Learning
- OLED
- Polymer
- QM
- Informatics
- Bootcamps
- India Life Sciences Seminar Series
- Global Materials Science Seminar Series 2019
- 2nd Life Science Bootcamp
- 4th Life Science Bootcamp
- 5th Life Science Bootcamp
- 6th Life Science Bootcamp
- 7th Life Science Bootcamp
- 8th Life Science Bootcamp
- 9th Life Science Bootcamp
- 1st Materials Bootcamp
- 2nd Materials Bootcamp
- Release
- Lunch and Learns
Structure-based Anti-Viral Design using Schrödinger’s Biologics Modeling Suite
Dr. Jianxin Duan
Schrödinger FellowSince prehistoric time, virus infection has been a threat to human health. Modulation of immune response is one of the successful approaches to prevent and treat infection. Vaccines provide sustained protective immunity by stimulating immune response of the host. Originally, vaccine design was centered around the isolate-inactivate-inject paradigm. In recent years, advances in structural biology and other technologies have introduced the era of rational vaccine design in which recombinant protein antigens are modified to achieve desired properties. Antiviral antibodies treat infections by rapidly removing virus particles and infected cells. Structure-based design of antibodies plays an important role in improving crucial biochemical properties such as affinity and aggregation. During this webinar, we show how Schrödinger's biologics modeling suite can be used in the engineering of protein antigens and antibodies to improve safety, efficacy, and developability of the therapeutic agents.